Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1992 Apr;140(4):823–830.

Application of a multiprobe RNase protection assay and junctional sequences to define V beta gene diversity in Sezary syndrome.

D H Kono 1, R Baccala 1, R S Balderas 1, S J Kovac 1, P W Heald 1, R L Edelson 1, A N Theofilopoulos 1
PMCID: PMC1886373  PMID: 1562047

Abstract

Nineteen patients with mycosis fungoides/Sezary syndrome (MF/SZ), a malignancy of the mature helper T-cell phenotype (CD4+TCR alpha beta+), were screened for clonotypic V beta expansions in peripheral blood with a multiprobe RNase protection assay. A different predominant V beta gene was identified in 9 of 14 patients with high peripheral blood CD4/CD8 ratios, whereas 4 of these patients showed T-cell expansions expressing V beta genes other than those included in the assay. In contrast, five patients with few, if any, malignant cells in the circulation had V beta expression levels similar to that in normal peripheral blood. A unique V-D-J sequence was found for each highly expressed V beta gene, thereby documenting monoclonality of the expanded T-cell populations. Polymerase chain reaction (PCR) primers specific for the D-J beta junction accurately identified the corresponding malignant clonotype in peripheral blood. The diverse TCR V beta gene usage found in these MF/SZ patients suggests that T-cell receptor (TCR) specificity has no bearing on this disease.

Full text

PDF
823

Images in this article

826Figure 1
on p.826
827Figure 2
on p.827
828Figure 4
on p.828

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisenberg A. C., Krontiris T. G., Mak T. W., Wilkes B. M. Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders. N Engl J Med. 1985 Aug 29;313(9):529–533. doi: 10.1056/NEJM198508293130901. [DOI] [PubMed] [Google Scholar]
  2. Baccala R., Kono D. H., Walker S., Balderas R. S., Theofilopoulos A. N. Genomically imposed and somatically modified human thymocyte V beta gene repertoires. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2908–2912. doi: 10.1073/pnas.88.7.2908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bertness V., Kirsch I., Hollis G., Johnson B., Bunn P. A., Jr T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med. 1985 Aug 29;313(9):534–538. doi: 10.1056/NEJM198508293130902. [DOI] [PubMed] [Google Scholar]
  4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  5. Clark D. M., Boylston A. W., Hall P. A., Carrel S. Antibodies to T cell antigen receptor beta chain families detect monoclonal T cell proliferation. Lancet. 1986 Oct 11;2(8511):835–837. doi: 10.1016/s0140-6736(86)92870-9. [DOI] [PubMed] [Google Scholar]
  6. Flug F., Pelicci P. G., Bonetti F., Knowles D. M., 2nd, Dalla-Favera R. T-cell receptor gene rearrangements as markers of lineage and clonality in T-cell neoplasms. Proc Natl Acad Sci U S A. 1985 May;82(10):3460–3464. doi: 10.1073/pnas.82.10.3460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Greaves M. F. Differentiation-linked leukemogenesis in lymphocytes. Science. 1986 Nov 7;234(4777):697–704. doi: 10.1126/science.3535067. [DOI] [PubMed] [Google Scholar]
  8. Hansen-Hagge T. E., Yokota S., Bartram C. R. Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences. Blood. 1989 Oct;74(5):1762–1767. [PubMed] [Google Scholar]
  9. Haynes B. F., Metzgar R. S., Minna J. D., Bunn P. A. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med. 1981 May 28;304(22):1319–1323. doi: 10.1056/NEJM198105283042202. [DOI] [PubMed] [Google Scholar]
  10. Ikuta K., Ogura T., Shimizu A., Honjo T. Low frequency of somatic mutation in beta-chain variable region genes of human T-cell receptors. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7701–7705. doi: 10.1073/pnas.82.22.7701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jack A. S., Boylston A. W., Carrel S., Grigor I. Cutaneous T-cell lymphoma cells employ a restricted range of T-cell antigen receptor variable region genes. Am J Pathol. 1990 Jan;136(1):17–21. [PMC free article] [PubMed] [Google Scholar]
  12. Jones S. E. Enigma of therapy for cutaneous T-cell lymphoma. J Natl Cancer Inst. 1990 Feb 7;82(3):169–170. doi: 10.1093/jnci/82.3.169. [DOI] [PubMed] [Google Scholar]
  13. Kanagawa O. In vivo T cell tumor therapy with monoclonal antibody directed to the V beta chain of T cell antigen receptor. J Exp Med. 1989 Nov 1;170(5):1513–1519. doi: 10.1084/jem.170.5.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kappler J., Kotzin B., Herron L., Gelfand E. W., Bigler R. D., Boylston A., Carrel S., Posnett D. N., Choi Y., Marrack P. V beta-specific stimulation of human T cells by staphylococcal toxins. Science. 1989 May 19;244(4906):811–813. doi: 10.1126/science.2524876. [DOI] [PubMed] [Google Scholar]
  15. Kaye F. J., Bunn P. A., Jr, Steinberg S. M., Stocker J. L., Ihde D. C., Fischmann A. B., Glatstein E. J., Schechter G. P., Phelps R. M., Foss F. M. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med. 1989 Dec 28;321(26):1784–1790. doi: 10.1056/NEJM198912283212603. [DOI] [PubMed] [Google Scholar]
  16. Knowles D. M. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia. Am J Pathol. 1989 Apr;134(4):761–785. [PMC free article] [PubMed] [Google Scholar]
  17. Korsmeyer S. J. Antigen receptor genes as molecular markers of lymphoid neoplasms. J Clin Invest. 1987 May;79(5):1291–1295. doi: 10.1172/JCI112951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kuzel T. M., Springer E., Roenigk H. H., Jr, Rosen S. T. Mycosis fungoides: time to define the best therapy. J Natl Cancer Inst. 1990 Feb 7;82(3):183–185. doi: 10.1093/jnci/82.3.183. [DOI] [PubMed] [Google Scholar]
  19. Levy R., Miller R. A. Therapy of lymphoma directed at idiotypes. J Natl Cancer Inst Monogr. 1990;(10):61–68. [PubMed] [Google Scholar]
  20. Li H. H., Gyllensten U. B., Cui X. F., Saiki R. K., Erlich H. A., Arnheim N. Amplification and analysis of DNA sequences in single human sperm and diploid cells. Nature. 1988 Sep 29;335(6189):414–417. doi: 10.1038/335414a0. [DOI] [PubMed] [Google Scholar]
  21. Macintyre E. A., d'Auriol L., Duparc N., Leverger G., Galibert F., Sigaux F. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias. J Clin Invest. 1990 Dec;86(6):2125–2135. doi: 10.1172/JCI114951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 May 11;248(4956):705–711. doi: 10.1126/science.2185544. [DOI] [PubMed] [Google Scholar]
  23. Nowell P. C., Croce C. M. Philip Levine award lecture. Chromosome translocations and oncogenes in human lymphoid tumors. Am J Clin Pathol. 1990 Aug;94(2):229–237. doi: 10.1093/ajcp/94.2.229. [DOI] [PubMed] [Google Scholar]
  24. O'Connor N. T., Wainscoat J. S., Weatherall D. J., Gatter K. C., Feller A. C., Isaacson P., Jones D., Lennert K., Pallesen G., Ramsey A. Rearrangement of the T-cell-receptor beta-chain gene in the diagnosis of lymphoproliferative disorders. Lancet. 1985 Jun 8;1(8441):1295–1297. doi: 10.1016/s0140-6736(85)92791-6. [DOI] [PubMed] [Google Scholar]
  25. Rabbitts T. H., Stinson A., Forster A., Foroni L., Luzzatto L., Catovsky D., Hammarström L., Smith C. I., Jones D., Karpas A. Heterogeneity of T-cell beta-chain gene rearrangements in human leukaemias and lymphomas. EMBO J. 1985 Sep;4(9):2217–2224. doi: 10.1002/j.1460-2075.1985.tb03917.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ralfkiaer E., O'Connor N. T., Crick J., Wantzin G. L., Mason D. Y. Genotypic analysis of cutaneous T-cell lymphomas. J Invest Dermatol. 1987 Jun;88(6):762–765. doi: 10.1111/1523-1747.ep12470458. [DOI] [PubMed] [Google Scholar]
  27. Toyonaga B., Mak T. W. Genes of the T-cell antigen receptor in normal and malignant T cells. Annu Rev Immunol. 1987;5:585–620. doi: 10.1146/annurev.iy.05.040187.003101. [DOI] [PubMed] [Google Scholar]
  28. Waldmann T. A. The arrangement of immunoglobulin and T cell receptor genes in human lymphoproliferative disorders. Adv Immunol. 1987;40:247–321. doi: 10.1016/s0065-2776(08)60241-2. [DOI] [PubMed] [Google Scholar]
  29. Weiss L. M., Wood G. S., Hu E., Abel E. A., Hoppe R. T., Sklar J. Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sezary syndrome. J Invest Dermatol. 1989 Apr;92(4):601–604. doi: 10.1111/1523-1747.ep12712131. [DOI] [PubMed] [Google Scholar]
  30. Wilson R. K., Lai E., Concannon P., Barth R. K., Hood L. E. Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families. Immunol Rev. 1988 Jan;101:149–172. doi: 10.1111/j.1600-065x.1988.tb00736.x. [DOI] [PubMed] [Google Scholar]
  31. Yamada M., Wasserman R., Lange B., Reichard B. A., Womer R. B., Rovera G. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment. N Engl J Med. 1990 Aug 16;323(7):448–455. doi: 10.1056/NEJM199008163230705. [DOI] [PubMed] [Google Scholar]
  32. Young R. C. Mycosis fungoides: the therapeutic search continues. N Engl J Med. 1989 Dec 28;321(26):1822–1824. doi: 10.1056/NEJM198912283212608. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES